In 2017, President Trump said that “one thing that’s always disturbed”1 him is that the US Food and Drug Administration (FDA) denies access to experimental drugs even “for a patient who’s terminal…[who] is not going to live more than four weeks [anyway.]”1 Fueled by emotionally charged anecdotes recirculated by libertarian political activists, 38 states have passed Right to Try laws. In 2017, the US Senate approved a bill that would create a national law (Box).2 As of December 2017, the US House of Representatives was considering the bill.
Bateman-House A, Robertson CT. The Federal Right to Try Act of 2017—A Wrong Turn for Access to Investigational Drugs and the Path Forward. JAMA Intern Med. 2018;178(3):321–322. doi:10.1001/jamainternmed.2017.8167
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: